Developer docs
API playgroundTry for free, no card

Search company profiles

Gaudium IVF Centre

Full company profile

uuid0023ipo

Namestring
Gaudium IVF Centre
Legal namestring
Gaudium IVF and Women Health Limited
Company typeenum
Public
Founded yearint
2009
Descriptiontext

Gaudium IVF Centre (legal entity: Gaudium IVF and Women Health Limited) is an India-based fertility services chain founded in 2009 by Dr. Manika Khanna and headquartered in New Delhi. The company operates a hub-and-spoke clinical network of 7 hub centres and 28 spokes across Delhi, Maharashtra, Karnataka, Bihar, Punjab, and Jammu & Kashmir, delivering a full spectrum of assisted reproductive technology services including IVF, ICSI, IUI, fertility preservation (egg, embryo, and sperm freezing), donor egg IVF, altruistic surrogacy, male infertility treatments, and the in-house MANTRANA counselling programme. It also runs a dedicated international patient services channel drawing medical tourists from 30+ countries, primarily the USA, Canada, UK, UAE, and Saudi Arabia.

The company's core technology layer is the AI-assisted clinical workflow built around two partner-developed systems — SiD (Sperm Identification Device) for sperm selection and ERICA (Embryo Ranking Intelligent Classification Assistant) for embryo ranking — integrated via a partnership with UK-based IVF 2.0. These systems analyze approximately 2.5 million parameters per sample and are supported by Gaudium's proprietary GAAT treatment module and standardized clinical SOPs across the network. Reported outcomes include a 58% first-attempt clinical pregnancy rate (an 8-point improvement post-AI adoption), an 85% cumulative success rate, and 6,000+ healthy babies delivered to date.

Gaudium generates revenue on a per-treatment-cycle basis with base IVF cycles starting at ₹2 lakh, complemented by diagnostics, cryopreservation, fertility counselling, and international patient services. In FY26 the company reported revenue of ₹104.35 crore (up 47.6% YoY), EBITDA of ₹37.70 crore, and profit after tax of ₹24.48 crore. Following a ₹165 crore IPO on NSE/BSE on February 27, 2026 — the first by an Indian fertility chain — the company is funding a rollout of 19 new IVF centres over two years (10 targeted by FY27) and a ₹15 crore women hospital in Lucknow via a 30-year lease, signaling an aggressive Tier-II/Tier-III expansion strategy.

Short descriptiontext

Gaudium IVF Centre is an India-based fertility services chain operating 35+ clinics via a hub-and-spoke model, delivering AI-assisted IVF, ICSI, fertility preservation, and surrogacy to domestic and international patients from 30+ countries.

Operating statusenum
Ipo
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility treatment services, assisted reproductive technology, in vitro fertilization, fertility preservation services, reproductive medicine
Industry2 codes
1Fertility, Reproductive Endocrinology & IVF Centers
CodeHLAFAJADPrimaryYes
2Reproductive Endocrinology & Infertility (IVF/Fertility)
CodeHLAKAJACPrimaryNo
NAICS code1 code
  • Family Planning Centers621410
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Fertility Services / Reproductive Healthcare
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1IVF Treatment Services
TypeOne Time License
Description

Core revenue from fertility treatments including IVF, ICSI, IUI procedures. Treatment cycle-based pricing with revenue generated per successful treatment cycle.

moneycontrol.com
2Diagnostic and Support Services
TypeProfessional Services
Description

Revenue from fertility diagnostics, egg freezing, embryo freezing, frozen embryo transfer, and fertility counseling services including MANTRANA program.

gaudiumivfcentre.com
3International Patient Services
TypeProfessional Services
Description

Medical tourism revenue from patients traveling from over 30 countries for fertility treatments.

gaudiumivfcentre.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details1 tier
1Standard IVF Treatment Cycle starting at ₹2,00,000
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Base IVF cycle prices starting at ₹2,00,000. Advanced procedures like ICSI and AI-powered embryology selection tools (SiD, ERICA) likely command premium pricing.

thehindu.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Gaudium IVF Centre provides comprehensive fertility treatments including IVF, ICSI, IUI, fertility preservation (egg, embryo, and sperm freezing), frozen embryo transfer, donor eggs IVF, altruistic surrogacy, and treatment for conditions such as PCOS/PCOD, endometriosis, and male infertility. The company operates a hub-and-spoke clinic network across India enhanced by AI-powered sperm selection (SiD) and embryo evaluation (ERICA) systems developed in partnership with UK-based IVF 2.0.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 58% first-attempt clinical pregnancy rate (improved 8 percentage points with AI adoption)
+4 more records
Product overview1 text field

Gaudium IVF Centre operates as a comprehensive fertility services provider offering a full spectrum of assisted reproductive technologies. The core offering centers on AI-powered IVF treatments utilizing proprietary SiD (Sperm Identification Device) and ERICA (Embryo Ranking Intelligent Classification Assistant) systems developed in partnership with UK-based IVF 2.0. The service portfolio includes primary treatments (IVF, ICSI, IUI), fertility preservation (egg, embryo, sperm freezing), advanced laboratory techniques (blastocyst culture, laser assisted hatching), and comprehensive support services including the MANTRANA counselling programme and international patient services. The company maintains a hub-and-spoke operational model with centers across India, supported by AI-driven clinical workflows designed to improve success rates.

Product and service21 records
1In Vitro Fertilization (IVF)
CategoryCore fertility treatment
Description

Primary assisted reproductive technology procedure where eggs are fertilized with sperm in a laboratory setting, representing the core fertility treatment service offered to couples experiencing infertility.

2Intracytoplasmic Sperm Injection (ICSI)
CategoryTreatment procedure
Description

Advanced fertility treatment where a single healthy sperm is directly injected into an egg, particularly effective for male factor infertility cases.

3Intrauterine Insemination (IUI)
CategoryTreatment procedure
Description

Fertility treatment where specially prepared sperm is placed directly into the uterus, bypassing cervical mucus to improve chances of fertilization.

4Egg Freezing
CategoryFertility preservation
Description

Cryopreservation service allowing women to preserve their eggs for future use, supporting delayed family planning and fertility preservation before medical treatments.

5Embryo Freezing
CategoryFertility preservation
Description

Cryopreservation service for storing embryos for future use in frozen embryo transfer cycles.

6Sperm Freezing
CategoryFertility preservation
Description

Cryopreservation service for storing sperm samples for future use in fertility treatments.

7Frozen Embryo Transfer (FET)
CategoryTreatment procedure
Description

Procedure where previously frozen embryos are thawed and transferred to the uterus, part of the cryopreservation and subsequent transfer cycle.

8Donor Eggs IVF
CategoryTreatment programme
Description

IVF treatment using donor eggs for couples where the female partner cannot produce viable eggs.

9Altruistic Surrogacy
CategoryTreatment programme
Description

Surrogacy programme conducted in compliance with new ART laws for couples unable to carry a pregnancy.

10PCOD/PCOS Treatment
CategoryTreatment procedure
Description

Specialized treatment for Polycystic Ovary Syndrome, addressing hormonal imbalances and ovulation problems that affect fertility.

11Endometriosis Treatment
CategoryTreatment procedure
Description

Medical and surgical management of endometriosis, a condition where uterine tissue grows outside the uterus affecting fertility.

12Male Infertility Treatments
CategoryTreatment procedure
Description

Comprehensive male fertility services including surgical sperm retrieval procedures (PESA, TESA, TESE), varicocelectomy, and ICSI treatment.

13MANTRANA Counselling Programme
CategorySupport service
Description

Comprehensive counselling programme designed to help couples cope with infertility-related stress, improving treatment outcomes through psychological support.

14Gynae Consultation
CategoryConsultation service
Description

Gynecology consultation services for women's reproductive health evaluation and pre-treatment assessment.

15Laparoscopy for Infertility
CategorySurgical procedure
Description

Minimally invasive surgical procedure for diagnosis and treatment of infertility-related conditions such as endometriosis, tubal blockages, and ovarian cysts.

16Infertility Surgeries
CategorySurgical procedure
Description

Surgical interventions for infertility including corrective procedures to address anatomical causes of infertility.

17Ovulation Induction
CategoryTreatment procedure
Description

Medical treatment using hormonal medications to stimulate ovulation in women who do not ovulate regularly.

18Diagnostic Services
CategoryDiagnostic service
Description

Comprehensive fertility diagnostics including primary investigations to identify causes of infertility.

19Environics Services
CategorySupport service
Description

Specialized environmental services aimed at optimizing conditions for fertility treatment success.

20International Patient Services
CategoryPatient service
Description

Dedicated services for international patients seeking fertility treatment in India, including coordination and support for patients from over 30 countries.

21Solution to Failed IVF
CategorySpecialist treatment programme
Description

Specialist treatment programme for patients who have experienced failed IVF cycles at other clinics, leveraging advanced protocols and AI-assisted embryo selection.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Mrs. Abhilasha Singh and M/s. Abhilasha Enterprises
Strategic tierMinorTypeOthersAnnounced on2026-06-25
Description

30-year lease agreement for establishing Gaudium Women Hospital in Lucknow, Uttar Pradesh, with project cost of ₹15 crore. Includes 10% net revenue share and ₹3 crore security deposit arrangement.

scanx.trade
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-01
Description

UK-based embryology innovation organization founded by embryologists Jacques Cohen and Alejandro Chave. Partnership to integrate SiD (Sperm Identification Device) and ERICA (Embryo Ranking Intelligent Classification Assistant) AI systems into Gaudium's clinical workflow, marking the first formal adoption of AI platforms by an IVF chain in India.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India's largest and most established IVF chain with a similar hub-and-spoke footprint across metros and Tier-II cities. Directly comparable on core IVF/ICSI/IUI services, ownership-LED private model, and rapid national expansion — and is the most likely consolidation counterpart for Gaudium.

TypeDirect peer
Description

Part of the CK Birla Group, Birla Fertility & IVF is a fast-scaling national chain running IVF, ICSI, IUI, andrology and fertility preservation with corporate-hospital-level brand trust. Comparable on standardised protocols, network rollout, and premium urban positioning.

TypeDirect peer
Description

Multi-country IVF chain (Gulf, India) founded by embryologist Dr. Human Fatemi, offering premium IVF, andrology, and PGT services. Comparable on clinical specialisation, embryology-led differentiation, and India–Gulf cross-border patient flows.

TypeDirect peer
Description

Backed by Asia Healthcare Holdings, Nova operates an India-wide network of fertility clinics offering IVF, ICSI, IUI and andrology services under a similar multi-centre model. Closest direct competitor on clinical menu, footprint strategy, and medical-tourism positioning.

TypeBroad incumbent
Description

The fertility arm of Apollo Hospitals, the largest hospital chain in India. Overlaps on IVF and reproductive services but as part of a much broader hospital portfolio, with a different unit-economics profile than Gaudium's pure-play fertility chain.

TypeBroad incumbent
Description

The fertility vertical of Manipal Hospitals, a leading hospital chain. Offers IVF and reproductive medicine as part of a broader multi-specialty provider, comparable on clinical service overlap though not on standalone chain economics.

TypeDirect peer
Description

Long-standing Indian IVF network founded by Dr. Hrishikesh Pai and Dr. Nandita Palshetkar, providing IVF, ICSI, fertility preservation and donor programmes to a similar metro-heavy patient mix.

TypeDirect peer
Description

Indian IVF chain founded by Dr. Gauri Agarwal with centres in Delhi NCR and other metros, offering IVF, ICSI, IUI, donor programmes and surrogacy. Comparable on urban-focused IVF services and founder-led specialty brand positioning.

TypeBroad incumbent
Description

World-leading fertility network resulting from the IVI–RMA merger, with global research programs in embryology and AI in IVF. Comparable on technology-led IVF practice and on offering a global reference benchmark for AI fertility tech partnerships such as Gaudium's IVF 2.0 deal.

TypeDirect peer
Description

Cloudnine's fertility vertical delivers IVF and reproductive medicine inside its women-and-child hospital network, serving overlapping urban Indian patients. Comparable on assisted reproduction services, premium pricing and brand-led patient acquisition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gaudium IVF Centre

Fertility Services / Reproductive Healthcaregaudiumivfcentre.com

Gaudium IVF Centre is an India-based fertility services chain operating 35+ clinics via a hub-and-spoke model, delivering AI-assisted IVF, ICSI, fertility preservation, and surrogacy to domestic and international patients from 30+ countries.

What Gaudium IVF Centre does

Gaudium IVF Centre (legal entity: Gaudium IVF and Women Health Limited) is an India-based fertility services chain founded in 2009 by Dr. Manika Khanna and headquartered in New Delhi. The company operates a hub-and-spoke clinical network of 7 hub centres and 28 spokes across Delhi, Maharashtra, Karnataka, Bihar, Punjab, and Jammu & Kashmir, delivering a full spectrum of assisted reproductive technology services including IVF, ICSI, IUI, fertility preservation (egg, embryo, and sperm freezing), donor egg IVF, altruistic surrogacy, male infertility treatments, and the in-house MANTRANA counselling programme. It also runs a dedicated international patient services channel drawing medical tourists from 30+ countries, primarily the USA, Canada, UK, UAE, and Saudi Arabia.

The company's core technology layer is the AI-assisted clinical workflow built around two partner-developed systems — SiD (Sperm Identification Device) for sperm selection and ERICA (Embryo Ranking Intelligent Classification Assistant) for embryo ranking — integrated via a partnership with UK-based IVF 2.0. These systems analyze approximately 2.5 million parameters per sample and are supported by Gaudium's proprietary GAAT treatment module and standardized clinical SOPs across the network. Reported outcomes include a 58% first-attempt clinical pregnancy rate (an 8-point improvement post-AI adoption), an 85% cumulative success rate, and 6,000+ healthy babies delivered to date.

Gaudium generates revenue on a per-treatment-cycle basis with base IVF cycles starting at ₹2 lakh, complemented by diagnostics, cryopreservation, fertility counselling, and international patient services. In FY26 the company reported revenue of ₹104.35 crore (up 47.6% YoY), EBITDA of ₹37.70 crore, and profit after tax of ₹24.48 crore. Following a ₹165 crore IPO on NSE/BSE on February 27, 2026 — the first by an Indian fertility chain — the company is funding a rollout of 19 new IVF centres over two years (10 targeted by FY27) and a ₹15 crore women hospital in Lucknow via a 30-year lease, signaling an aggressive Tier-II/Tier-III expansion strategy.

Gaudium IVF Centre firmographics

Firmographics
Name
Gaudium IVF Centre
Legal name
Gaudium IVF and Women Health Limited
Website
https://gaudiumivfcentre.com
Company type
Public
Founded year
2009
Operating status
Ipo
Headcount range
51–100 employees
Short description
Gaudium IVF Centre is an India-based fertility services chain operating 35+ clinics via a hub-and-spoke model, delivering AI-assisted IVF, ICSI, fertility preservation, and surrogacy to domestic and international patients from 30+ countries.
Ownership category
akta.pro rank

Gaudium IVF Centre industry classification

Industry
Product category
Fertility Services / Reproductive Healthcare
NAICS
Family Planning Centers (621410)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
akta.pro secondary industry
Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

  • Fertility treatment services
  • Assisted reproductive technology
  • In vitro fertilization
  • Fertility preservation services
  • Reproductive medicine

Where Gaudium IVF Centre is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices8 records

Markets served

Gaudium IVF Centre business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. IVF Treatment Services: Core revenue from fertility treatments including IVF, ICSI, IUI procedures. Treatment cycle-based pricing with revenue generated per successful treatment cycle.
  2. Diagnostic and Support Services: Revenue from fertility diagnostics, egg freezing, embryo freezing, frozen embryo transfer, and fertility counseling services including MANTRANA program.
  3. International Patient Services: Medical tourism revenue from patients traveling from over 30 countries for fertility treatments.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard IVF Treatment Cycle starting at ₹2,00,000

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Gaudium IVF Centre product offering

Product offering

Core offering

Gaudium IVF Centre provides comprehensive fertility treatments including IVF, ICSI, IUI, fertility preservation (egg, embryo, and sperm freezing), frozen embryo transfer, donor eggs IVF, altruistic surrogacy, and treatment for conditions such as PCOS/PCOD, endometriosis, and male infertility. The company operates a hub-and-spoke clinic network across India enhanced by AI-powered sperm selection (SiD) and embryo evaluation (ERICA) systems developed in partnership with UK-based IVF 2.0.

Product overview

Gaudium IVF Centre operates as a comprehensive fertility services provider offering a full spectrum of assisted reproductive technologies. The core offering centers on AI-powered IVF treatments utilizing proprietary SiD (Sperm Identification Device) and ERICA (Embryo Ranking Intelligent Classification Assistant) systems developed in partnership with UK-based IVF 2.0. The service portfolio includes primary treatments (IVF, ICSI, IUI), fertility preservation (egg, embryo, sperm freezing), advanced laboratory techniques (blastocyst culture, laser assisted hatching), and comprehensive support services including the MANTRANA counselling programme and international patient services. The company maintains a hub-and-spoke operational model with centers across India, supported by AI-driven clinical workflows designed to improve success rates.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vitro Fertilization (IVF) Primary assisted reproductive technology procedure where eggs are fertilized with sperm in a laboratory setting, representing the core fertility treatment service offered to couples experiencing infertility.
  • Intracytoplasmic Sperm Injection (ICSI) Advanced fertility treatment where a single healthy sperm is directly injected into an egg, particularly effective for male factor infertility cases.
  • Intrauterine Insemination (IUI) Fertility treatment where specially prepared sperm is placed directly into the uterus, bypassing cervical mucus to improve chances of fertilization.
  • Egg Freezing Cryopreservation service allowing women to preserve their eggs for future use, supporting delayed family planning and fertility preservation before medical treatments.
  • Embryo Freezing Cryopreservation service for storing embryos for future use in frozen embryo transfer cycles.
  • Sperm Freezing Cryopreservation service for storing sperm samples for future use in fertility treatments.
  • Frozen Embryo Transfer (FET) Procedure where previously frozen embryos are thawed and transferred to the uterus, part of the cryopreservation and subsequent transfer cycle.
  • Donor Eggs IVF IVF treatment using donor eggs for couples where the female partner cannot produce viable eggs.
  • Altruistic Surrogacy Surrogacy programme conducted in compliance with new ART laws for couples unable to carry a pregnancy.
  • PCOD/PCOS Treatment Specialized treatment for Polycystic Ovary Syndrome, addressing hormonal imbalances and ovulation problems that affect fertility.
  • Endometriosis Treatment Medical and surgical management of endometriosis, a condition where uterine tissue grows outside the uterus affecting fertility.
  • Male Infertility Treatments Comprehensive male fertility services including surgical sperm retrieval procedures (PESA, TESA, TESE), varicocelectomy, and ICSI treatment.
  • MANTRANA Counselling Programme Comprehensive counselling programme designed to help couples cope with infertility-related stress, improving treatment outcomes through psychological support.
  • Gynae Consultation Gynecology consultation services for women's reproductive health evaluation and pre-treatment assessment.
  • Laparoscopy for Infertility Minimally invasive surgical procedure for diagnosis and treatment of infertility-related conditions such as endometriosis, tubal blockages, and ovarian cysts.
  • Infertility Surgeries Surgical interventions for infertility including corrective procedures to address anatomical causes of infertility.
  • Ovulation Induction Medical treatment using hormonal medications to stimulate ovulation in women who do not ovulate regularly.
  • Diagnostic Services Comprehensive fertility diagnostics including primary investigations to identify causes of infertility.
  • Environics Services Specialized environmental services aimed at optimizing conditions for fertility treatment success.
  • International Patient Services Dedicated services for international patients seeking fertility treatment in India, including coordination and support for patients from over 30 countries.
  • Solution to Failed IVF Specialist treatment programme for patients who have experienced failed IVF cycles at other clinics, leveraging advanced protocols and AI-assisted embryo selection.

Quantifiable outcome

  • 58% first-attempt clinical pregnancy rate (improved 8 percentage points with AI adoption)
  • +4 more outcomes

Companies that use Gaudium IVF Centre

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Gaudium IVF Centre technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature4 records

Gaudium IVF Centre partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • Mrs. Abhilasha Singh and M/s. Abhilasha EnterprisesminorOthers · 25 June 202630-year lease agreement for establishing Gaudium Women Hospital in Lucknow, Uttar Pradesh, with project cost of ₹15 crore. Includes 10% net revenue share and ₹3 crore security deposit arrangement.
  • IVF 2.0coreTechnology or Integration · 1 April 2026UK-based embryology innovation organization founded by embryologists Jacques Cohen and Alejandro Chave. Partnership to integrate SiD (Sperm Identification Device) and ERICA (Embryo Ranking Intelligent Classification Assistant) AI systems into Gaudium's clinical workflow, marking the first formal adoption of AI platforms by an IVF chain in India.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Gaudium IVF Centre competitors and assessment

Company assessment

Direct peers

  • Indira IVF: India's largest and most established IVF chain with a similar hub-and-spoke footprint across metros and Tier-II cities. Directly comparable on core IVF/ICSI/IUI services, ownership-LED private model, and rapid national expansion — and is the most likely consolidation counterpart for Gaudium.
  • Birla Fertility & IVF: Part of the CK Birla Group, Birla Fertility & IVF is a fast-scaling national chain running IVF, ICSI, IUI, andrology and fertility preservation with corporate-hospital-level brand trust. Comparable on standardised protocols, network rollout, and premium urban positioning.
  • ART Fertility Clinics: Multi-country IVF chain (Gulf, India) founded by embryologist Dr. Human Fatemi, offering premium IVF, andrology, and PGT services. Comparable on clinical specialisation, embryology-led differentiation, and India–Gulf cross-border patient flows.
  • Nova IVF Fertility: Backed by Asia Healthcare Holdings, Nova operates an India-wide network of fertility clinics offering IVF, ICSI, IUI and andrology services under a similar multi-centre model. Closest direct competitor on clinical menu, footprint strategy, and medical-tourism positioning.
  • Bloom IVF Group: Long-standing Indian IVF network founded by Dr. Hrishikesh Pai and Dr. Nandita Palshetkar, providing IVF, ICSI, fertility preservation and donor programmes to a similar metro-heavy patient mix.
  • Seeds of Innocence IVF: Indian IVF chain founded by Dr. Gauri Agarwal with centres in Delhi NCR and other metros, offering IVF, ICSI, IUI, donor programmes and surrogacy. Comparable on urban-focused IVF services and founder-led specialty brand positioning.
  • Cloudnine Group of Hospitals: Cloudnine's fertility vertical delivers IVF and reproductive medicine inside its women-and-child hospital network, serving overlapping urban Indian patients. Comparable on assisted reproduction services, premium pricing and brand-led patient acquisition.

Broad incumbents

  • Apollo Fertility: The fertility arm of Apollo Hospitals, the largest hospital chain in India. Overlaps on IVF and reproductive services but as part of a much broader hospital portfolio, with a different unit-economics profile than Gaudium's pure-play fertility chain.
  • Manipal Fertility: The fertility vertical of Manipal Hospitals, a leading hospital chain. Offers IVF and reproductive medicine as part of a broader multi-specialty provider, comparable on clinical service overlap though not on standalone chain economics.
  • IVI RMA Global (IVI RMA): World-leading fertility network resulting from the IVI–RMA merger, with global research programs in embryology and AI in IVF. Comparable on technology-led IVF practice and on offering a global reference benchmark for AI fertility tech partnerships such as Gaudium's IVF 2.0 deal.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Gaudium IVF Centre social profiles

Digital presence

Gaudium IVF Centre financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gaudium IVF Centre leadership team

Management profile

Number of profiles

Profiles1 record

Gaudium IVF Centre funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gaudium IVF Centre M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gaudium IVF Centre

What does Gaudium IVF Centre do?

Gaudium IVF Centre provides comprehensive fertility treatments including IVF, ICSI, IUI, fertility preservation (egg, embryo, and sperm freezing), frozen embryo transfer, donor eggs IVF, altruistic surrogacy, and treatment for conditions such as PCOS/PCOD, endometriosis, and male infertility. The company operates a hub-and-spoke clinic network across India enhanced by AI-powered sperm selection (SiD) and embryo evaluation (ERICA) systems developed in partnership with UK-based IVF 2.0.

Is Gaudium IVF Centre a public or private company?

Gaudium IVF Centre is a public company. It is classified as public and is currently ipo.

When was Gaudium IVF Centre founded?

Gaudium IVF Centre was founded in 2009. It employs 51 to 100 people.

Where is Gaudium IVF Centre based?

Gaudium IVF Centre is headquartered in New Delhi, India, in the Asia region.

How does Gaudium IVF Centre make money?

Three revenue lines are on record. IVF Treatment Services are the primary driver. The others are diagnostic and Support Services and international Patient Services.

Who are Gaudium IVF Centre's main competitors?

Direct peers on record are Indira IVF, Birla Fertility & IVF, ART Fertility Clinics, Nova IVF Fertility, Bloom IVF Group, Seeds of Innocence IVF and Cloudnine Group of Hospitals. Broad incumbents are Apollo Fertility, Manipal Fertility and IVI RMA Global (IVI RMA).

Does Gaudium IVF Centre have an API?

No public API is recorded for Gaudium IVF Centre.

What industry is Gaudium IVF Centre in?

Gaudium IVF Centre's product category is Fertility Services / Reproductive Healthcare. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXGaudium IVF schedules 11th AGM for September 28, 2026Gaudium IVF & Women Health scheduled its 11th AGM for September 28, 2026, at 2:00 pm via video conferencing. The notice and FY26 annual report will be sent electronically, with e-voting via National Securities Depository Limited. Shareholders holding shares as of the cut-off date can vote.Business StandardGaudium IVF and Women Health consolidated net profit declines 42.02% in the June 2026 quarterGaudium IVF and Women Health reported a 42.02% decline in net profit to Rs 1.78 crore for the quarter ended June 2026, compared to Rs 3.07 crore in the same period of 2025. Despite the drop in profitability, the company's sales increased by 9.12% to Rs 19.38 crore during the quarter.TradingView#GAUDIUMIVF for NSE:GAUDIUMIVF by akilan14793Gaudium IVF & Women Health Ltd. is actively traded on NSE with a recent closing price of 148.45 INR, showing a daily increase of 4.67 INR or 3.25%.The TribuneIndia's First Listed IVF Company, Gaudium IVF, Unveils AI Powered Signature Labs, Kicking Off Planned 19 Centre ExpansionGaudium IVF and Women Health Limited, India's first publicly listed IVF chain, launched its first new center in South Delhi as part of a planned 19-centre expansion, featuring its proprietary AI-powered Gaudium Signature Lab. The new facility integrates AI embryology technologies including SiD for sperm assessment and ERICA for embryo evaluation, with the Signature Lab model intended for replication across all future centers. The expansion addresses growing demand for fertility care in India driven by delayed parenthood and increasing awareness of assisted reproductive technologies.DevdiscourseGaudium IVF Expands with Cutting-Edge Fertility Care CenterGaudium IVF and Women Health Limited inaugurated a new fertility center in South Delhi as part of a 19-centre expansion strategy across India. The new facility features AI-powered embryology technologies including a Sperm Identification Device and Embryo Ranking Intelligent Classification Assistant, integrated within the company's proprietary Signature Lab framework. Under the leadership of Dr. Manika Khanna, the company aims to enhance accessibility to advanced fertility treatments nationwide amid growing demand for specialized reproductive services.ScanXGaudium IVF rectifies comparative figures in FY26 resultsGaudium IVF & Women Health filed a corrigendum to its FY26 audited results, correcting regrouping errors in FY25 comparative figures, which auditors confirmed had no impact on FY26 results. The company also received board approval to establish Gaudium Women Hospital in Lucknow with a project cost of ₹15 crore, involving a land lease and revenue-sharing arrangements.Business TodayGaudium IVF Plans 19 New IVF Centres As Revenue Reaches ₹104 CroreGaudium IVF and Women Health Ltd reported FY26 revenue of ₹104.35 crore, up 47.6% year-on-year, with EBITDA at ₹37.70 crore and profit after tax at ₹24.48 crore. The company plans to add 19 new IVF centres using IPO proceeds, with three centres expected to become operational shortly and a total of 10 targeted by FY27, expanding into Tier-II markets and strengthening its spoke network. Gaudium IVF recently partnered with IVF 2.0 to introduce AI-led embryology tools and maintains a 58% first-attempt clinical pregnancy success rate.Business News TodayStocks to Watch Today: Wipro, TCS, HDFC Life, Saatvik Green Energy, IRB Infrastructure, JSW Steel, IFB Industries, Gaudium IVF in focus on 10 AprilThe article reports on key stock market updates for April 10, highlighting focus on several companies including Tata Consultancy Services, JSW Steel, Wipro, and HDFC Life Insurance, among others. It details quarterly earnings, strategic moves, and regulatory actions affecting these firms.Fortune IndiaGaudium IVF plans to open 19 centres over two yearsGaudium IVF, India's first publicly listed IVF chain, debuted on domestic exchanges on February 27, 2026, after raising ₹165 crore through its IPO and announced plans to open 19 new IVF centres over the next two years. The Delhi-based fertility healthcare services provider is also deploying AI-powered tools developed by IVF 2.0 to improve embryo and sperm selection, aiming to boost success rates and drive growth in an market where only 2% of India's infertile population currently seeks treatment. The company is targeting expansion beyond metros into tier 2 and tier 3 cities, with construction already underway on a couple of new centres.Fortune IndiaGaudium IVF plans to open 19 centres over two yearsGaudium IVF, India's first publicly listed IVF chain, debuted on domestic exchanges on February 27, 2026, after raising ₹165 crore through its IPO. The Delhi-based fertility healthcare services provider has outlined plans to open 19 new IVF centres over the next two years, with execution already underway on some locations. The chairperson stated that the company remains focused on maintaining its SOP-driven clinical excellence while pursuing aggressive expansion.